28,000+ Happy Customers

CDSCO Registration Services

eFileSeva provides reliable and expert CDSCO Registration services to help manufacturers, importers, and pharmaceutical brand owners secure mandatory regulatory approvals from the Central Drugs Standard Control Organization (CDSCO). Our end-to-end guidance covers registration on the SUGAM portal, identification of correct application categories for drugs, cosmetics, and medical devices, technical dossier compilation, and post-registration regulatory compliance under the Drugs and Cosmetics Act, 1940 and associated Rules.

A CDSCO Registration is statutory for businesses looking to import, manufacture high-risk medical devices, or launch new drugs and cosmetics in India. Whether you require an Import License (Form 10 for drugs, Form MD-15 for medical devices, or Form COS-1 for cosmetics) or central manufacturing authorisations (Form MD-9 for Class C & D devices), CDSCO serves as the Central Licensing Authority. Obtaining these registrations ensures your products meet national safety, efficacy, and quality standards for lawful commercial distribution in the Indian market.

The exact application pathway depends on the product classification, manufacturing site location, and intended use. The process involves preparing intricate technical dossiers such as Device Master Files (DMF), Plant Master Files (PMF), Power of Attorney (POA) for Indian Authorized Agents, and Free Sale Certificates (FSC). eFileSeva simplifies the technical complexities of the SUGAM / MD-Online filing process, delivering professional guidance to resolve departmental queries and ensure successful approval.

Google Rating 4.9 / 5.0
Trustpilot Rating 4.8 / 5.0

Request a Call Back

100% Secure • No Spam

Key Details for CDSCO Registration

eFileSeva provides expert assistance for CDSCO Registration, including SUGAM portal onboarding, identification of correct registration categories for drugs, cosmetics, and medical devices, technical dossier preparation, and application filing with the Central Licensing Authority for lawful import and manufacturing in India.

    • # Topic Details
    1 What is CDSCO Registration CDSCO Registration refers to the central regulatory authorisation granted by the Central Drugs Standard Control Organization under the Drugs and Cosmetics Act, 1940. It is mandatory for activities regulated at the national level, such as importing pharmaceutical products, obtaining manufacturing licences for high-risk medical devices, and securing approvals for new drugs or clinical investigations.
    2 Who Needs CDSCO Registration Any entity engaged in the import of drugs, cosmetics, or medical devices, as well as manufacturers of Class C & D (high-risk) medical devices, clinical research organisations (CROs), and businesses launching "New Drugs" in the Indian market must register with CDSCO. Foreign manufacturers must register via an Indian Authorized Agent (IAA).
    3 Major Registration Categories & Forms CDSCO handles various central authorisations via the SUGAM / MD-Online portals:
    • Drug Import: Registration Certificate (Form 9) and Import Licence (Form 10).
    • Medical Device Import: Import Licence in Form MD-15 for all classes.
    • Cosmetic Import: Registration Certificate in Form COS-2 (applied via Form COS-1).
    • High-Risk Manufacturing: Manufacturing Licence in Form MD-9 for Class C & D devices.
    4 The SUGAM Portal & Account Setup All central applications are filed through the SUGAM online portal. The process begins with "User Registration," where the applicant's credentials, identity proof, and manufacturing/wholesale drug licences (for importers) are verified by CDSCO officials before the account is activated for filing.
    5 Indian Authorized Agent (IAA) Requirement For foreign manufacturers, CDSCO mandates the appointment of an Indian Authorized Agent. The IAA must hold a valid Wholesale Drug License or Medical Device Sale Registration and is legally responsible for the quality and regulatory compliance of the imported products in India.
    6 Processing Timeline CDSCO scrutiny is highly technical and rigorous. Timelines depend on the product category:
    • Cosmetics / Fixed Dose Combinations: 3 to 6 months.
    • Medical Devices (Import/Mfg): 4 to 9 months (depending on clinical data review or site audit requirements).
    • New Drug Approvals: Subject to Subject Expert Committee (SEC) reviews.
    7 Government Fee & Professional Cost Fees are charged in US Dollars (USD) for import registrations and in Indian Rupees (INR) for domestic manufacturing. Fees depend on the number of manufacturing sites and individual product variants being registered. Professional fees for dossier drafting, technical gap analysis, and portal management are billed separately.
    8 Required Documents for CDSCO Filing Commonly required technical dossiers include:
    • Power of Attorney (POA): Legal authorization from the foreign manufacturer to the Indian agent.
    • Free Sale Certificate (FSC): Proof that the product is sold in the country of origin.
    • Device/Drug Master Files: Detailed manufacturing processes, stability data, and quality control specs.
    • Plant Master File (PMF): Details of the manufacturing facility's infrastructure and GMP status.
    9 Validity & Licence Retention Registrations and licences issued by CDSCO generally have perpetual validity subject to the payment of a licence retention fee every 5 years. Compliance with post-approval conditions and timely retention payments are crucial to avoid cancellation or de-registration of products.
    10 Post-Approval Compliance The registrant must maintain rigorous post-market surveillance, report adverse events (Pharmacovigilance/Materiovigilance), comply with Unique Device Identification (UDI) for devices, and ensure that every imported consignment is accompanied by the requisite certificates of analysis and import licence copies.
    11 Related Services In addition to CDSCO registration, eFileSeva provides support for:
    Indian Authorized Agent (IAA) Legal Representation
    Drug & Medical Device Import Licence (Form 10 / MD-15)
    Cosmetic Import Registration (Form COS-2)
    Wholesale Drug License (Form 20B/21B) for IAA
    Medical Device Sale Registration (MD-42)
    Import Export Code (IEC) Registration
    Trademark Registration for Global Pharma Brands
    Clinical Trial & New Drug Approval Assistance

    Key Details for CDSCO Registration

    eFileSeva provides professional assistance for CDSCO Registration, including SUGAM portal user registration, identification of correct registration categories for drugs, cosmetics, and medical devices, technical dossier preparation (DMF, PMF), and application filing with the Central Licensing Authority for lawful import and high-risk manufacturing in India.

    # Topic Details
    1 What is CDSCO Registration? CDSCO Registration refers to the central regulatory authorisation granted by the Central Drugs Standard Control Organization. It is mandatory for pharmaceutical activities regulated at the national level, such as importing drugs and cosmetics, manufacturing high-risk medical devices, and conducting clinical trials under the Drugs and Cosmetics Act, 1940.
    2 Who Needs CDSCO Registration? Any entity engaged in the import of drugs, medical devices, or finished cosmetics into India requires registration. It is also mandatory for manufacturers of Class C & D (high-risk) medical devices, sponsors of clinical investigations, and foreign manufacturers intending to market products in India through an Indian Authorized Agent (IAA).
    3 Major Registration Categories & Forms Applications are handled via the SUGAM / MD-Online portals based on the activity:
    • Drug Import: Form 10 (Import Licence) & Form 41 (Registration Certificate).
    • Medical Device Import: Form MD-15 (covers all classes A, B, C, & D).
    • Cosmetic Import: Form COS-2 (Registration Certificate for finished goods).
    • High-Risk Mfg: Form MD-9 (Manufacturing Licence for Class C & D devices).
    4 The SUGAM Portal & User Registration The first step is creating a SUGAM Portal account. CDSCO verifies the applicant's credentials, including the wholesale drug licence (for importers), identity proof of the authorised signatory, and manufacturing site details, before granting access to file technical applications.
    5 Indian Authorized Agent (IAA) Requirement Foreign manufacturers must appoint a local Indian Authorized Agent. The agent must hold a valid Wholesale Drug License or Medical Device Sale Registration (MD-42) and is legally responsible for product quality, vigilance, and regulatory communication with the Central Licensing Authority.
    6 Processing Timeline CDSCO scrutiny is rigorous and technical. Timelines vary by category:
    • Cosmetic Import: Typically 3 to 6 months.
    • Medical Devices: Typically 4 to 9 months (depending on site audit or clinical data review).
    • New Drug Registration: Subject to Subject Expert Committee (SEC) review schedules.
    7 Government Fee & Professional Cost Statutory fees for import registrations are usually charged in US Dollars (USD) per manufacturing site and per product category. Domestic manufacturing fees are in INR. Professional charges for dossier compilation, gap analysis of technical files, and portal management are charged separately.
    8 Required Technical Dossiers Key documents include the Power of Attorney (POA), Free Sale Certificate (FSC) from the country of origin, Device/Drug Master Files (DMF), Plant Master Files (PMF), stability data, sterilization validation, and quality-management system certificates (ISO 13485).
    9 Validity & Licence Retention Most CDSCO registrations and licences now have perpetual validity, provided the licence retention fee is deposited every 5 years as per the prescribed schedule. Failure to pay the retention fee results in the cancellation of the registration.
    10 Post-Registration Compliance Once registered, the entity must comply with labelling norms (printing the Import Licence number), adverse event reporting (Pharmacovigilance/Materiovigilance), post-market surveillance, and obtaining prior approval for any material changes to the product or manufacturing site (Form MD-35 or equivalent).
    11 Related Services Along with CDSCO Registration, eFileSeva can assist with:
    Indian Authorized Agent (IAA) Legal Representation
    Wholesale Drug License (Form 20B/21B) for Agents
    Medical Device Sale Registration (MD-42)
    Technical Dossier (DMF/PMF) Drafting & Gap Analysis
    Import Export Code (IEC) Registration
    Trademark Registration for Global Pharma Brands
    BIS Certification for Specific Electronic Devices
    FSSAI Registration for Nutraceutical Imports

    Key Benefits & Uses of CDSCO Registration

    A CDSCO Registration enables manufacturers, importers, and pharmaceutical brand owners to operate in accordance with the Central Drugs Standard Control Organization mandates under the Drugs and Cosmetics Act, 1940. It is essential for lawful import, high-risk manufacturing, and market entry for regulated drugs, medical devices, and cosmetics, ensuring national safety, efficacy, and quality standards are met.

    Central Regulatory & Legal Compliance

    CDSCO Registration provides the highest level of regulatory approval in India, authorising entities to act as primary manufacturers or importers under central licensing oversight.

    • Mandatory compliance for high-risk product categories
    • Central Licensing Authority (CLA) verification
    • Lawful handling of New Drugs and Investigational Devices

    Global Brand Trust & B2B Credibility

    Securing central registration demonstrates that a brand—whether domestic or foreign—meets India’s stringent technical and clinical benchmarks, improving supply chain confidence.

    • Essential for foreign manufacturer onboarding
    • Improves chances in government and hospital tenders
    • Validates quality with Indian Authorized Agents (IAA)

    Enables Import & Market Access

    Registration on the SUGAM portal is the primary gateway for importing finished drugs, cosmetics, and medical devices (Class A-D) into the Indian market for commercial distribution.

    • Supports Form 10, COS-2, and MD-15 import routes
    • Facilitates customs clearance with valid registrations
    • Authorises bulk stock distribution to licensed wholesalers

    Adherence to Global GMP & Standards

    CDSCO scrutiny ensures that manufacturing sites—both domestic and overseas—adhere to Good Manufacturing Practices (GMP) and ISO quality management benchmarks.

    • Ensures site master file (PMF) regulatory compliance
    • Validates product stability and sterilization data
    • Promotes safer formulations for the Indian public

    Post-Market Vigilance & Traceability

    Registration mandates a framework for reporting adverse events and maintaining batch-wise traceability, crucial for recall management and pharmacovigilance.

    • Compliance with Materiovigilance Programme (MvPI)
    • Mandates adverse event reporting to the CLA
    • Enables efficient batch-level recall and tracking

    Business Scalability & Portfolio Growth

    A SUGAM portal account allows for easy addition of new product categories and variants (Endorsements) under existing manufacturing or import frameworks.

    • Streamlines addition of Class C/D high-risk devices
    • Supports global manufacturer partnerships in India
    • Simplifies 5-yearly license retention processes
    Important:

    While State Licensing Authorities (SLA) manage retail/wholesale and low-risk manufacturing, CDSCO acts as the Central Licensing Authority for all Imports, New Drugs, Clinical Trials, and Class C & D Medical Devices. All such applications must be filed electronically via the SUGAM or MD-Online portal.

    Key Details for CDSCO Registration

    eFileSeva provides professional assistance for CDSCO Registration, including SUGAM portal user registration, identification of correct registration categories for drugs, cosmetics, and medical devices, technical dossier preparation (DMF, PMF), and application filing with the Central Licensing Authority for lawful import and high-risk manufacturing in India.

    # Topic Details
    1 What is CDSCO Registration? CDSCO Registration refers to the central regulatory authorisation granted by the Central Drugs Standard Control Organization. It is mandatory for pharmaceutical activities regulated at the national level, such as importing drugs and cosmetics, manufacturing high-risk medical devices, and conducting clinical trials under the Drugs and Cosmetics Act, 1940.
    2 Who Needs CDSCO Registration? Any entity engaged in the import of drugs, medical devices, or finished cosmetics into India requires registration. It is also mandatory for manufacturers of Class C & D (high-risk) medical devices, sponsors of clinical investigations, and foreign manufacturers intending to market products in India through an Indian Authorized Agent (IAA).
    3 Licence Scope & Product Categorisation The scope covers authorisations that fall under the Central Licensing Authority (CLA). This includes Import Registrations for foreign manufacturing sites and Manufacturing Licences for sophisticated or high-risk medical equipment. The product must be categorised correctly (e.g., New Drug, Investigational Medical Device, Notified Cosmetic) to determine the applicable regulatory pathway.
    4 Registration Categories & Authority The applicable approval is handled via central portals (SUGAM / MD-Online):
    • Drug Import (Form 10 / Form 41) — handled by CDSCO HQ for importing bulk drugs and finished formulations.
    • Medical Device Import (Form MD-15) — central licence covering Class A, B, C, and D medical devices.
    • Cosmetic Import (Form COS-2) — registration of foreign manufacturing sites for finished cosmetics.
    • High-Risk Mfg (Form MD-9) — manufacturing licence for Class C & D medical devices.
    5 Indian Authorized Agent (IAA) & Eligibility Foreign manufacturers must appoint a local Indian Authorized Agent. The IAA must hold a valid Wholesale Drug License (20B/21B) or Medical Device Sale Registration (MD-42). The agent is legally responsible for product quality, post-market surveillance, and regulatory liabilities in India.
    6 Processing Timeline Processing timelines depend on technical dossier scrutiny, clinical data reviews, and site audit scheduling (if required). Import registrations typically take 3 to 6 months, while high-risk manufacturing involving site inspections may take 6 to 9 months.
    7 Government Fee & Professional Cost Government fees for import are generally charged in US Dollars (USD) per manufacturing site and per product category. Domestic manufacturing fees are in INR. Professional charges for dossier compilation, gap analysis, and portal management are billed separately.
    8 Application Process (SUGAM Portal) The process begins with User Registration on the SUGAM portal. CDSCO verifies the applicant's credentials (wholesale licence, identity of signatory) before allowing technical filing. Once technical dossiers are uploaded and fees paid, the CLA conducts a technical review and may issue deficiency letters or "queries" before final approval.
    9 Required Documents (Technical Dossiers) Requirements are rigorous. Common documents include: Power of Attorney (POA), Free Sale Certificate (FSC), Device/Drug Master Files (DMF), Plant Master File (PMF), ISO 13485 / GMP certificates, stability data, labels, instructions for use, and clinical evaluation reports (where applicable).
    10 Validity & Licence Retention Most registrations issued by CDSCO now have perpetual validity, provided the licence retention fee is paid every 5 years. Compliance with original licence conditions and reporting of any material changes is mandatory to maintain the registration status.
    11 Post-Registration Compliance Licensees must maintain post-market surveillance, report adverse events (Materiovigilance/Pharmacovigilance), comply with Unique Device Identification (UDI) norms, and ensure all imported consignments carry the valid Import Licence number on labels. Material changes to the site or formulation require prior notification or amendment.
    12 Related Services Along with CDSCO Registration, eFileSeva can assist with:
    Indian Authorized Agent (IAA) Legal Representation
    Wholesale Drug License (Form 20B/21B) for Agents
    Medical Device Sale Registration (MD-42)
    Import Export Code (IEC) Registration
    Technical Dossier (DMF/PMF) Drafting & Gap Analysis
    Licence Retention / Amendment / Category Addition
    Trademark Registration for Global Pharma Brands
    GST Registration & Return Filing

    Documents Required for CDSCO Registration

    eFileSeva helps you compile and verify the technical dossiers required for CDSCO Registration, ensuring your application for an Import License or Manufacturing License is complete for the Central Licensing Authority. Exact requirements depend on the registration category (Medical Device, Drug, or Cosmetic) and whether you are a domestic manufacturer or an Indian Authorized Agent (IAA) representing a foreign site.

    Applicant & Indian Agent KYC

    Identity details of the Indian Authorized Agent (IAA) or the authorised signatory of the domestic manufacturing unit.

    • ID & Address Proof of the Authorised Signatory (Aadhaar/Passport)
    • PAN Card of the Business Entity and Signatory
    • SUGAM Portal Login Credentials (if already registered)
    • Digital Signature Certificate (DSC) of the applicant

    Business & Legal Documents

    Statutory business licenses required to act as an importer or central manufacturer under CDSCO rules.

    • Wholesale Drug License (Form 20B/21B) or MD-42 Registration
    • Certificate of Incorporation / Partnership Deed
    • Import Export Code (IEC) issued by DGFT
    • Power of Attorney (POA) from the Foreign Manufacturer (duly notarised/apostilled)

    Foreign Site & Regulatory Proof

    Compliance documents from the country of origin for import registrations (Form 41, COS-2, or MD-15).

    • Free Sale Certificate (FSC) from the National Regulatory Authority
    • Manufacturing License of the overseas facility
    • ISO 13485 / CE Certificate / USFDA Approval (for Devices)
    • Certificate of Pharmaceutical Product (CPP) as per WHO guidelines

    Technical Dossiers (DMF & PMF)

    Intricate technical files detailing the product specifications and the manufacturing site’s capabilities.

    • Device Master File (DMF) / Drug Master File
    • Plant Master File (PMF) of the manufacturing site
    • Detailed Manufacturing Process & Flow Chart
    • Quality Control measures & Stability data
    • Clinical Evaluation Report / Performance Evaluation (if applicable)

    Labels, IFU & Safety Data

    Documentation ensuring the product meets Indian labelling and safety disclosure standards.

    • Draft Labels as per Indian Drug/Device/Cosmetic Rules
    • Instructions for Use (IFU) / Patient Information Leaflet
    • Sterilization Validation Reports (for sterile products)
    • Biocompatibility & Toxicology Reports
    • Material Safety Data Sheet (MSDS)

    Declarations & SUGAM Filing

    Final undertakings and fee receipts required for submission on the central MD-Online or SUGAM portal.

    • TR-6 Challan / Payment Receipt of Government Fees (in USD or INR)
    • Self-Declaration regarding no conviction/penalty
    • Technical Query (TQ) responses from previous filings (if any)
    • Covering Letter detailing the purpose of the application
    • List of all product variants and pack sizes

    Dossier Complexity & Risk Classification

    CDSCO requirements vary significantly between low-risk and high-risk products.

    The checklist above is a high-level summary. For Class C & D Medical Devices or New Drugs, clinical trial data and Subject Expert Committee (SEC) presentations are mandatory. For Cosmetic Imports, heavy metal and hexachlorophene declarations are essential. eFileSeva provides a customized gap-analysis checklist based on your specific product classification before portal upload.

    Timeline for CDSCO Registration in India

    The CDSCO Registration process is a centralized regulatory workflow conducted primarily through the SUGAM / MD-Online portals. It begins with User Registration and verification of credentials, followed by the compilation of intricate technical dossiers such as Device Master Files (DMF) or Plant Master Files (PMF). Once the application is submitted to the Central Licensing Authority (CLA), it undergoes rigorous technical scrutiny, which may include Subject Expert Committee (SEC) reviews, site audits (for high-risk manufacturing), and the resolution of technical queries. Processing timelines are highly dependent on the product risk category and the completeness of clinical/technical data.

    Day 1–7
    SUGAM Portal Onboarding & User Registration

    The first step involves creating a user account on the SUGAM portal. The applicant must upload identity proof, the Wholesale Drug License (for IAA) or Manufacturing License, and a covering letter. CDSCO officials verify these credentials on-site or via the portal to activate the account for technical filing.

    Day 7–30
    Technical Dossier Compilation & Legalization

    This is the most critical phase. Documentation includes the Power of Attorney (POA), Free Sale Certificate, Device/Drug Master Files, and GMP certificates. For foreign sites, legal documents must be notarized/apostilled in the country of origin before they are acceptable for Indian regulatory submission.

    Day 30–45
    Technical Filing & Fee Payment (USD/INR)

    The completed dossiers are uploaded to the central CDSCO portal. The statutory government fee is paid (typically in US Dollars for import applications via TR-6 challan). After payment verification, the application reaches the technical desk of the respective CDSCO division.

    90–180 Days
    Technical Scrutiny, Queries & Approval

    CDSCO experts review the safety, quality, and efficacy data. If gaps are found, they issue Technical Queries (TQ). The applicant must respond promptly. Following successful review and/or Subject Expert Committee (SEC) presentation, the Registration Certificate (e.g., Form 41, MD-15, or COS-2) is issued.

    Note:

    The above timeline is indicative for standard CDSCO Registration applications. High-risk Class C & D medical devices or "New Drugs" may require Subject Expert Committee (SEC) reviews or mandatory site inspections, which can extend the timeline by several months. Timely response to deficiency letters and technical queries is essential to prevent application rejection. Import of goods should only be initiated after the Import License is formally visible and downloadable from the SUGAM/MD-Online portal.

    Process for CDSCO Registration in India

    The CDSCO Registration process is a centralized regulatory workflow conducted primarily through the SUGAM / MD-Online portals. It begins with identifying the correct category — Import of Drugs, Cosmetics, or Medical Devices, or Central Manufacturing Licences under the Drugs and Cosmetics Act, 1940. The process involves user account activation, compilation of intricate technical dossiers (DMF/PMF), submission to the Central Licensing Authority (CLA), technical query resolution, and potential Subject Expert Committee (SEC) reviews before final approval.

    01
    Portal Onboarding & User Account Registration

    Create a user account on the SUGAM portal (for Drugs and Cosmetics) or the MD-Online portal (for Medical Devices). This involves uploading the Wholesale Drug License (for agents) or Manufacturing License, Aadhaar/Passport of the authorised signatory, and a covering letter. CDSCO officials verify these credentials to activate the account for technical filings.

    02
    Indian Authorized Agent (IAA) & Legalization

    For foreign manufacturing sites, appoint an Indian Authorized Agent (IAA) via a Power of Attorney (POA). The POA and other overseas documents like the Free Sale Certificate (FSC) and Manufacturing License must be duly notarised and apostilled (or attested by the Indian Embassy) in the country of origin to be legally valid for Indian regulatory submission.

    03
    Technical Dossier Compilation (DMF & PMF)

    Compile the Device Master File (DMF) or Drug Master File, which includes detailed manufacturing processes, stability data, sterilization validation, materials of construction, and performance evaluation reports. Simultaneously, prepare the Plant Master File (PMF) detailing the site’s infrastructure, equipment, and ISO 13485 / GMP compliance status.

    04
    Application Filing & Statutory Fee Payment

    Select the applicable registration form (e.g., Form 40, COS-1, MD-14, or MD-7), upload the technical dossiers, and pay the government fee. Fees for import registrations are typically paid in US Dollars (USD) via the TR-6 challan system. Once submitted, the application is assigned to the technical desk of the respective CDSCO division (Medical Device, New Drug, or Cosmetic).

    05
    Technical Scrutiny, Queries & SEC Review

    CDSCO experts review the safety and efficacy data. They may issue Technical Queries (TQ) or deficiency letters via the portal. The applicant must provide detailed technical justifications. For high-risk devices or "New Drugs," a presentation before the Subject Expert Committee (SEC) may be required. Site audits for high-risk manufacturing (Class C & D) are also conducted at this stage.

    06
    Registration Issuance & Post-Market Vigilance

    On successful verification, the Registration Certificate / Import Licence (Form 41, COS-2, MD-15, etc.) is issued. The registrant must comply with labelling requirements, maintain Materiovigilance / Pharmacovigilance records, report adverse events to CDSCO, and pay licence retention fees every 5 years to maintain the validity of the registration and continue commercial supply in India.

    Get Free Consultation Schedule a Call

    Why organisations trust us

    18K+

    Clients Served

    100+

    On-Time Filings

    20+ Yrs

    of Expertise

    4.8

    Google Rating

    Chat on WhatsApp +91 9582497933

    Registrations & Compliances Required After CDSCO Registration

    After obtaining a CDSCO Registration (Import Licence or Central Manufacturing Licence), importers, domestic manufacturers, and Indian Authorized Agents (IAA) must adhere to rigorous technical and quality standards under the Drugs and Cosmetics Act, 1940 and Medical Devices Rules, 2017. Maintenance of registration involves periodic retention filings, post-market surveillance, vigilance reporting, and ensuring every commercial consignment meets national safety benchmarks.

    Registration / Compliance When You May Need It Key Benefit / Purpose
    CDSCO Licence Retention Compliance
    		Required to maintain the validity of central registrations (Form 41, MD-15, COS-2, etc.). The licence retention fee must be deposited on the SUGAM portal every 5 years before the deadline. Ensures perpetual validity of the registration, preventing de-listing of products and ensuring uninterrupted import or manufacturing operations.
    Post-Approval Changes (Amendment / Form MD-35)
    		Required whenever there is a material change in the manufacturing site, product design, formulation, business name, or constitution of the Indian agent. Major changes require prior approval, while minor ones require notification. Keeps the CDSCO records synchronized with actual operations and prevents customs clearance delays due to data mismatches.
    Pharmacovigilance & Materiovigilance Reporting
    		Mandatory on an ongoing basis. Importers and manufacturers must report any serious adverse events (SAE) or device failures to CDSCO via the MvPI (Materiovigilance) or Pharmacovigilance system within prescribed timelines. Protects public health by monitoring product safety in the real world and demonstrates the licensee's commitment to patient safety.
    UDI Implementation & Labelling Norms
    		Applicable to all medical device registrants. Products must carry the Unique Device Identification (UDI) and the Import Licence/Registration number on the labels as per the notified rules. Ensures product authenticity, prevents counterfeiting, and enables efficient tracking and tracing of batches across the Indian supply chain.
    Post-Market Surveillance (PMS) Reports
    		Registrants must collect and analyze data on product performance in the market and submit Periodic Safety Update Reports (PSUR) or PMS data to the Central Licensing Authority as specified in the licence conditions. Validates the long-term efficacy of the product and is often a prerequisite for licence retention or clinical trial waivers for future variants.
    Batch Release & Certificate of Analysis (COA)
    		Required for every imported or manufactured batch. Importers must ensure that a Certificate of Analysis from the manufacturing site accompanies each consignment for customs clearance and distribution. Confirms that each specific batch meets the specifications approved by CDSCO during the registration process.
    Import Export Code (IEC) Maintenance
    		Mandatory for all importers. The IEC (issued by DGFT) must be kept active and updated annually on the DGFT portal to ensure smooth commercial shipments. Essential for Customs (ICEGATE) integration and the actual physical import of drugs, devices, and cosmetics into India.
    GST Compliance & IGST Payments
    		Applies to every B2B transaction and import. Importers must pay Integrated GST (IGST) at the time of customs clearance and file monthly returns. Allows the entity to claim Input Tax Credit (ITC) and maintain a clean tax profile for government and institutional tenders.
    Corporate Tax & Audit Compliance
    		Income-tax filing and Tax Audit (if applicable) must be completed annually based on the entity’s turnover and constitution. Ensures overall business legitimacy and supports banking and foreign exchange remittances for import payments.
    Wholesale / Sale Registration (Form 20B/21B or MD-42)
    		Required to sell the registered products in the Indian market. While CDSCO grants the Import Licence, the actual sale/distribution requires a license from the State Licensing Authority. Enables the registrant to legally bill and supply products to pharmacies, hospitals, and sub-distributors.
    Shop & Establishment / Local Permissions
    		Applies to the warehouse or office premises of the Indian Authorized Agent or manufacturer as per local municipal laws. Ensures the business premises comply with local labor, safety, and commercial zoning regulations.
    Additional Product Endorsements
    		Whenever the brand owner launches a new variant, model, or pack size not covered in the original Registration Certificate, an endorsement application must be filed on the SUGAM portal. Allows for rapid scaling of the product portfolio under an already-verified manufacturing site registration.

    CDSCO Registered Entity vs Unregistered: Why Central Approval Matters

    Obtaining CDSCO Registration (Central Licensing Authority approval) is a statutory requirement for businesses importing drugs, medical devices, and cosmetics, as well as manufacturers of high-risk medical equipment under the Drugs and Cosmetics Act, 1940. It directly affects the ability to legally clear shipments through Customs, act as an Indian Authorized Agent (IAA) for global brands, participate in government tenders, and ensure post-market vigilance and safety. Compare the key differences below to understand why CDSCO Registration is the backbone of the regulated pharma and med-tech supply chain in India.

    Feature Business With CDSCO Registration Business Without CDSCO Registration
    1. Legal Import & High-Risk Manufacturing Centrally Compliant
    Lawfully permitted to import finished drugs, medical devices (Class A-D), and cosmetics, or manufacture high-risk (Class C & D) devices within the scope of Central Licensing Authority mandates.     		Illegal & Non-Compliant
    Commercial import or high-risk manufacturing without CDSCO approval is a criminal offence, attracting severe penalties, imprisonment, and permanent debarment from the sector.
    2. Customs & Port Clearance (ICEGATE) Enables seamless customs clearance at notified air/sea ports. Valid Import Licences (Form 10 / MD-15) are integrated with ICEGATE for automated verification of consignments. Consignments are blocked at the port of entry. Lacking central registration leads to shipment seizure, heavy demurrage charges, and potential destruction of goods by Customs.
    3. Authority Verification & SUGAM Portal Receives a unique registration on the SUGAM / MD-Online portal. Global manufacturers and domestic buyers can verify the authenticity of the Import Licence/Registration Certificate online. Not Verifiable at the National Level
    Lacks official credentials on CDSCO portals, leading to immediate rejection by hospital procurement boards, e-commerce platforms, and clinical investigation partners.
    4. Indian Authorized Agent (IAA) Status Empowered to act as the legal representative for Foreign Manufacturers. Authorised to issue valid legal undertakings and handle regulatory communication for global brands. Cannot legally represent any overseas manufacturing site. Foreign brands cannot enter the Indian market through an unregistered or unauthorized agent.
    5. Vigilance & Safety Reporting Integrated into the Pharmacovigilance / Materiovigilance Programme of India (MvPI). Maintains a formal channel for reporting adverse events and managing product recalls. Operates outside the safety net. Inability to report adverse events leads to high legal liability for patient harm and immediate "blacklisting" by the Central Drugs Controller.
    6. Tenders & Institutional Supply Access Eligible to participate in GeM (Government e-Marketplace), Ministry of Health, Army, and Railway tenders where valid CDSCO Import/Manufacturing licences are a mandatory pre-qualification. Technically disqualified from all organized government and private hospital supply chains that mandate valid central regulatory authorisations.
    7. Traceability & UDI Compliance Complies with Unique Device Identification (UDI) and batch-traceability norms, ensuring that every product unit is authentic and follows national labelling standards. High risk of being categorized as a supplier of "Spurious" or "Misbranded" goods due to non-compliance with central labelling and identification requirements.
    8. Cost & Long-Term Business Stability Involves transparent USD/INR statutory fees and technical dossier preparation, ensuring perpetual business validity through periodic 5-yearly retention filings. Avoids upfront registration costs but risks complete business collapse due to legal prosecution, shipment loss, and loss of supply contracts from global principals.
    9. Expansion & Portfolio Growth Supports rapid scaling of the product range through Category Endorsements under existing factory/site registrations, allowing for easy launch of new models and variants. Expansion is impossible without foundational central registration. Every new product launch remains an illegal activity, compounding the regulatory risk.
    10. Best Suited For Importers of Drugs/Cosmetics, Indian Authorized Agents (IAA), Manufacturers of Class C & D Medical Devices, and businesses aiming for global-standard clinical research and distribution. Entities only dealing in items that are specifically exempt from the purview of the Drugs and Cosmetics Act or the Medical Devices Rules (e.g., non-medicated general goods).

    Ready to Secure Your CDSCO Registration?

    Get expert guidance from eFileSeva for CDSCO Registration — SUGAM portal onboarding, Indian Authorized Agent representation, Technical Dossier (DMF/PMF) compilation, application filing, resolution of queries from the Central Licensing Authority, and 5-yearly retention management.

    Talk to an Expert

    Frequently Asked Questions

    Find answers to common questions about CDSCO Registration, including SUGAM portal onboarding, Indian Authorized Agent (IAA) requirements, technical dossier preparation, application filing for drugs, medical devices, and cosmetics, USD/INR government fees, Subject Expert Committee (SEC) reviews, site audits, and post-approval retention compliance.

    CDSCO Registration refers to the central regulatory approval granted by the Central Drugs Standard Control Organization. It is mandatory for pharmaceutical and medical device activities regulated at the national level, such as the import of drugs and cosmetics, manufacturing of high-risk (Class C & D) medical devices, and approvals for New Drugs or clinical investigations.

    Registration is required by importers of pharmaceutical products, foreign manufacturers intending to sell in India, domestic manufacturers of Class C & D medical devices, and clinical research sponsors. For overseas entities, the application must be filed through a locally appointed Indian Authorized Agent (IAA).

    The SUGAM Portal is CDSCO’s official e-governance interface for online application filing. It is used to submit technical dossiers, pay statutory fees, and track the status of Import Licenses, Registration Certificates, and Manufacturing Licenses. All central regulatory communications and query responses happen exclusively through this portal.

    An Indian Authorized Agent must be a legally established entity in India holding a valid Wholesale Drug License (Form 20B/21B) or a Medical Device Sale Registration (MD-42). The IAA acts as the foreign manufacturer's legal representative, responsible for product quality and regulatory vigilance in the Indian market.

    Applicants must submit a Plant Master File (PMF) detailing the manufacturing site and a Device/Drug Master File (DMF) detailing the product specifications. Other critical documents include the Power of Attorney (POA), Free Sale Certificate (FSC), stability data, ISO 13485 / GMP certificates, and sterilization validation reports.

    Yes, for high-risk categories. Domestic manufacturing of Class C & D medical devices requires a mandatory site audit by CDSCO officials. For import registrations, CDSCO may conduct an Overseas Manufacturing Site Inspection if the clinical data or GMP status requires physical verification.

    Fees for import registrations are typically charged in US Dollars (USD) per manufacturing site and per product category (e.g., $1000 for a drug registration certificate). Domestic manufacturing fees are paid in INR. Professional drafting and dossier gap-analysis charges are billed separately from these statutory dues.

    Processing timelines vary by category: Cosmetic Imports typically take 3-6 months, while Medical Device and Drug registrations can take 6-9 months depending on Subject Expert Committee (SEC) reviews and technical query (TQ) resolution cycles.

    Registrations and licences granted by CDSCO have perpetual validity, provided the licensee pays the licence retention fee every 5 years. If the retention fee is not paid before the due date, the registration is deemed cancelled.

    For New Drugs or complex Class C & D Medical Devices, CDSCO refers the application to an SEC comprised of clinical specialists. The applicant may be required to present clinical data and safety rationale before the committee to secure a positive recommendation for approval.

    Any material change (e.g., change in manufacturing process, site address, or product design) must be reported to CDSCO. Depending on the nature of the change, you may need to file a Post-Approval Change (PAC) application or a fresh registration to maintain legal compliance.

    Still Have Questions?

    Talk to the eFileSeva team for guidance on CDSCO Registration — technical dossier gap analysis, Indian Authorized Agent representation, SUGAM portal filing, Subject Expert Committee (SEC) presentation support, and end-to-end regulatory strategy for your global pharma or med-tech brand.

    Talk to an Expert

    Trusted by Global & Domestic Brands for CDSCO Registration in India

    Importers, foreign manufacturers, Indian Authorized Agents (IAA), and manufacturers of high-risk medical devices rely on eFileSeva for professional assistance with CDSCO Registration — SUGAM portal onboarding, risk-based classification, technical dossier (DMF/PMF) compilation, Central Licensing Authority filing, Technical Query (TQ) resolution, and post-approval regulatory compliance.

    500+

    CDSCO Registration Filings

    2000+

    Global Brands Assisted

    Central

    Regulatory Support (CLA)

    End-to-End

    Technical Dossier Guidance

    Transparent CDSCO / SUGAM Portal Filing Process
    Specialized DMF, PMF & POA Dossier Compilation
    Vigilance, PAC Amendments & 5-Yearly Retention Support